Important statistical considerations in the evaluation of post‐market studies to assess whether opioids with abuse‐deterrent properties result in reduced abuse in the community
Kunthel By; Jana K. McAninch; Stephine L. Keeton; Alex Secora; Cynthia J. Kornegay; Catherine S. Hwang; Thomas Ly; Mark S. Levenson
Author Information: US Food and Drug Administration
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.